Trials / Withdrawn
WithdrawnNCT00556153
[F-18]Fluoro-DOPA PET Imaging of Brain Tumors in Children
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Children's Hospital Medical Center, Cincinnati · Academic / Other
- Sex
- All
- Age
- 5 Years – 15 Years
- Healthy volunteers
- Not accepted
Summary
The first phase of the study will investigate if there is increased uptake of \[F-18\]FDOPA in pediatric brain tumors when compared to normal brain tissue.
Detailed description
The first phase of the study will investigate if there is increased uptake of \[F-18\]FDOPA in pediatric brain tumors when compared to normal brain tissue. Tne subjects between ages 5 and 17 years will be studies, to determine if there is increased uptake of \[F-18\]FDOPA in pediatric brain tumors when compared to normal brain tissue. Drug safety will also be monitored.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [F-18]Fluoro-DOPA PET, a diagnostic radiopharmaceutical | A single dosage of the diagnostic drug will be administered to individuals who meet inclusion criteria after informed consent. |
Timeline
- Start date
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2007-11-09
- Last updated
- 2013-01-08
Source: ClinicalTrials.gov record NCT00556153. Inclusion in this directory is not an endorsement.